HCM II Acquisition [HOND] vs Cartesian Growth [RENEW] Detailed Stock Comparison
TLDR: Quick Comparison Summary
We found some data (3 metrics), but not enough for a complete comparison. Metrics like P/E ratio, profitability, and financial health are still available in the detailed tabs below.
View Metrics Details
Vital Metrics Comparison
Note: Limited metrics are available for comparison. Check other tabs for more detailed analysis.
| Metric | HCM II Acquisition Corp. | Cartesian Growth Corporation II | Better |
|---|---|---|---|
| Price-to-Book Ratio | 2.29 | N/A | N/A |
| Debt-to-Equity Ratio | 0.00 | 0.11 | Tie |
| EV/EBITDA | N/A | -3.24 | N/A |
| Profit Margin (TTM) | 0.00% | N/A | N/A |
| Operating Margin (TTM) | 0.00% | N/A | N/A |
| Return on Equity | N/A | 12.76% | N/A |
| Return on Assets (TTM) | N/A | 9.65% | N/A |
| Free Cash Flow (TTM) | N/A | $-814,232 | N/A |
| 1-Year Return | 80.58% | 38.02% | HCM II Acquisition Corp. |
| Enterprise Value | $518.53M | $6.34M | HCM II Acquisition Corp. |
| Short % of Float | 5.27% | N/A | N/A |
HCM II Acquisition Corp. vs Cartesian Growth Corporation II Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| HCM II Acquisition Corp. | 0.87% | -5.99% | 18.06% | 63.26% | 66.57% | 70.19% |
| Cartesian Growth Corporation II | -1.85% | -0.05% | -0.59% | 3.06% | 20.19% | 15.36% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| HCM II Acquisition Corp. | 80.58% | 81.12% | 81.12% | 81.12% | 81.12% | 81.12% |
| Cartesian Growth Corporation II | 38.02% | 39.28% | 18.82% | 108.54% | 83.25% | 83.25% |
Performance & Financial Health Analysis: HCM II Acquisition Corp. vs Cartesian Growth Corporation II
| Metric | HOND | RENEW |
|---|---|---|
| Market Information | ||
| Market Cap | $518.65M | $0 |
| Market Cap Category | Small cap | Micro cap |
| 10 Day Avg. Volume | 4,761,989 | 1,113 |
| 90 Day Avg. Volume | 3,391,410 | 371 |
| Last Close | $18.04 | $138.87 |
| 52 Week Range | $9.97 - $31.50 | $110.08 - $147.87 |
| % from 52W High | -42.73% | -6.09% |
| All-Time High | $31.47 (Oct 15, 2025) | $147.87 (Jul 23, 2025) |
| % from All-Time High | -42.68% | -6.09% |
| Growth Metrics | ||
| Quarterly Revenue Growth | N/A | N/A |
| Quarterly Earnings Growth | N/A | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.00% | N/A |
| Operating Margin (TTM) | 0.00% | N/A |
| Return on Equity (TTM) | N/A | 0.13% |
| Debt to Equity (MRQ) | 0.00 | 0.11 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | $-0.49 | N/A |
| Cash per Share (MRQ) | $0.00 | N/A |
| Operating Cash Flow (TTM) | $-323,234 | $-118,461 |
| Levered Free Cash Flow (TTM) | $0 | $8.21M |
| Dividends | ||
| Last 12-Month Dividend Yield | N/A | N/A |
| Last 12-Month Dividend | N/A | $0.00 |
Valuation & Enterprise Metrics Analysis: HCM II Acquisition Corp. vs Cartesian Growth Corporation II
| Metric | HOND (Nov 14, 2025) | RENEW (Apr 13, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| Price to Sales (TTM) | N/A | N/A |
| Price to Book (MRQ) | 2.29 | N/A |
| Market Capitalization | ||
| Market Capitalization | $518.65M | $0 |
| Enterprise Value | $518.53M | $6.34M |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | N/A | N/A |
| Enterprise to EBITDA | N/A | -3.24 |
| Risk & Other Metrics | ||
| Beta | N/A | N/A |
| Book Value per Share (MRQ) | $-0.49 | N/A |
Financial Statements Comparison: HCM II Acquisition Corp. vs Cartesian Growth Corporation II
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | HOND | RENEW (2024) |
|---|---|---|
| Revenue/Sales | N/A | 0 |
| Cost of Goods Sold | N/A | N/A |
| COGS % of Revenue | - | - |
| Gross Profit | N/A | N/A |
| Gross Margin | - | - |
| Research & Development | N/A | N/A |
| Operating Income (EBIT) | N/A | -1.04M |
| Operating Margin | - | - |
| EBITDA | N/A | -1.95M |
| EBITDA Margin | - | - |
| Pre-Tax Income | N/A | 8.21M |
| Pre-Tax Income % of Revenue | - | - |
| Income Tax | N/A | N/A |
| Income Tax % of Revenue | - | - |
| Net Income (Profit) | N/A | 8.21M |
| Profit Margin | - | - |
Balance Sheet & Liquidity Metrics
| Metric | HOND | RENEW (2024) |
|---|---|---|
| Cash & Equivalents | 668,089 | 236,700 |
| Total Current Assets | 820,167 | 438,847 |
| Total Current Assets % of Revenue | - | - |
| Total Current Liabilities | 458,624 | 3.48M |
| Total Current Liabilities % of Revenue | - | - |
| Long-Term Debt | N/A | 4.48M |
| Long-Term Debt % of Revenue | - | - |
| Total Shareholders Equity | 224.89M | 64.30M |
| Retained Earnings | -10.31M | -20.26M |
| Retained Earnings % of Revenue | - | - |
| Property, Plant & Equipment | N/A | N/A |
Cash Flow Statement Comparison
| Metric | HOND | RENEW (2024) |
|---|---|---|
| Operating Cash Flow | N/A | -118,461 |
| Operating Cash Flow % of Revenue | - | - |
| Capital Expenditures | N/A | N/A |
| Free Cash Flow | N/A | -814,232 |
| FCF Margin | - | - |
| Debt Repayment | N/A | N/A |
| Common Stock Repurchase | N/A | -99.61M |
Short Interest & Institutional Ownership Analysis
| Metric | HOND | RENEW |
|---|---|---|
| Shares Short | 1.21M | N/A |
| Short Ratio | 0.40 | N/A |
| Short % of Float | 5.27% | N/A |
| Shares Outstanding | 28.75M | 13.00M |
| Float Shares | 21.05M | N/A |
| % Held by Insiders | 0.00% | N/A |
| % Held by Institutions | 97.23% | N/A |
| % Held by Public | 2.77% | N/A |
Dividend Analysis & Yield Comparison: HCM II Acquisition Corp. vs Cartesian Growth Corporation II
| Metric | HOND | RENEW |
|---|---|---|
| Last 12-Month Dividend | N/A | $0.00 |
| Last 12-Month Dividend Yield | N/A | N/A |
| 3-Year Avg Annual Dividend | N/A | $0.01 |
| 3-Year Avg Dividend Yield | N/A | 0.22% |
| 3-Year Total Dividends | N/A | $0.02 |
| Ex-Dividend Date | N/A | Dec 01, 2022 |